E-selectin-binding peptide

General Information


DRACP ID  DRACP04825

Peptide Name   E-selectin-binding peptide

Sequence  CDSDSDITWDQLWDLMK

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C89H131N21O32S2

Absent amino acids  AEFGHNPRVY

Common amino acids  D

Mass  235686

Pl  3.54

Basic residues  1

Acidic residues  5

Hydrophobic residues  5

Net charge  -4

Boman Index  -4101

Hydrophobicity  -73.53

Aliphatic Index  68.82

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  11000

Absorbance 280nm  687.5

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17121909

Title  How molecular imaging is speeding up antiangiogenic drug development

Doi 10.1158/1535-7163.MCT-06-0395

Year  2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.